FDA Clears Karl Storz Rubina Lens Exoscope for Open Surgery

Stroke Care and Outcomes Among Patients Experiencing Homelessness: Translating Evidence into Clinical Practice

A large meta-analysis found people experiencing homelessness receive fewer time-critical stroke treatments, highlighting urgent needs for equitable triage, standardized care pathways, and stronger post-discharge support.

FDA Clears Karl Storz Rubina Lens Exoscope for Open Surgery

FDA clearance of a 4K fluorescence-guided exoscope enhances open surgery by improving visualization, teamwork, and real-time tissue perfusion assessment to support safer surgical decisions.

New Guidelines Help Identify Patients at Risk of Sudden Cardiac Death

Updated pediatric heart guidelines promote earlier screening for sudden cardiac death risk, helping clinicians identify warning signs, order timely testing, and prevent life-threatening cardiac events.

Choosing the Optimal Antihypertensive for Brain Health: A Deep Dive into ARB vs. ACEI Initiation and Cognitive Trajectories

New research suggests ARBs may better preserve long-term cognitive function than ACE inhibitors in some hypertensive adults, supporting more brain-conscious treatment decisions without changing current therapy universally.

Johnson & Johnson Expands U.S. Availability Of Intraocular Lens

Johnson & Johnson’s new FDA-approved EDOF intraocular lens expands cataract surgery options by improving vision across distances, reducing reading-glass dependence, and minimizing common visual disturbances.